Biology Reference
In-Depth Information
hypogonadotropic hypogonadism in a highly consanguineous family. J Clin Endocrinol
Metab 96(3):E536-E545
41. Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, O'Rahilly S,
Aparicio SA (2005) Two novel missense mutations in g protein-coupled receptor 54 in a
patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 90:1849-1855
42. Wahab F, Quinton R, Seminara SB (2011) The kisspeptin signaling pathway and its role in
human isolated GnRH defi ciency. Mol Cell Endocrinol 346:29-36
43. Goodman RL, Lehman MN, Smith JT, Coolen LM, de Oliveira CV, Jafarzadehshirazi MR,
Pereira A, Iqbal J, Caraty A, Ciofi P, Clarke IJ (2007) Kisspeptin neurons in the arcuate nucleus
of the ewe express both dynorphin A and neurokinin B. Endocrinology 148:5752-5760
44. Rance NE (2009) Menopause and the human hypothalamus: evidence for the role of kisspeptin/
neurokinin B neurons in the regulation of estrogen negative feedback. Peptides 30:111-122
45. Hrabovszky E, Ciofi P, Vida B, Horvath MC, Keller E, Caraty A, Bloom SR, Ghatei MA,
Dhillo WS, Liposits Z, Kallo I (2010) The kisspeptin system of the human hypothalamus:
sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B
neurons. Eur J Neurosci 31:1984-1998
46. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO,
Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK (2009)
TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for
neurokinin B in the central control of reproduction. Nat Genet 41:354-358
47. Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach
E, Silveira LF, Costa EM, de Mendonca BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata
M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico
AC, Seminara SB (2010) TAC3/TACR3 mutations reveal preferential activation of
gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal
in adulthood. J Clin Endocrinol Metab 95(6):2857-2867
48. Yang JJ, Caligioni CS, Chan YM, Seminara SB (2012) Uncovering novel reproductive defects
in neurokinin B receptor null mice: closing the gap between mice and men. Endocrinology
153:1498-1508
49. Pitteloud N, Boepple PA, DeCruz S, Valkenburgh SB, Crowley WF Jr, Hayes FJ (2001) The
fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal
associated with a homozygous mutation in the gonadotropin-releasing hormone receptor.
J Clin Endocrinol Metab 86:2470-2475
50. Dewailly D, Boucher A, Decanter C, Lagarde JP, Counis R, Kottler ML (2002) Spontaneous
pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-
releasing hormone receptor gene. Fertil Steril 77:1288-1291
51. Pitteloud N, Acierno JS Jr, Meysing AU, Dwyer AA, Hayes FJ, Crowley WF Jr (2005)
Reversible Kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single
family with a mutation in the fi broblast growth factor receptor 1 gene. J Clin Endocrinol Metab
90:1317-1322
52. Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, Cole LW, Pearce SH, Lee
H, Boepple P, Crowley WF Jr, Pitteloud N (2007) Reversal of idiopathic hypogonadotropic
hypogonadism. N Engl J Med 357:863-873
53. Ribeiro RS, Vieira TC, Abucham J (2007) Reversible Kallmann syndrome: report of the fi rst
case with a KAL1 mutation and literature review. Eur J Endocrinol 156:285-290
54. Sinisi AA, Asci R, Bellastella G, Maione L, Esposito D, Elefante A, De Bellis A, Bellastella
A, Iolascon A (2008) Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp)
presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum
Reprod 23:2380-2384
55. Young J, George JT, Tello JA, Francou B, Bouligand J, Guiochon-Mantel A, Brailly-Tabard S,
Anderson RA, Millar RP (2012) Kisspeptin restores pulsatile LH secretion in patients with
neurokinin B signaling defi ciencies: physiological, pathophysiological and therapeutic impli-
cations. Neuroendocrinology. doi:
10.1159/000336376
56. Chan YM, Broder-Fingert S, Paraschos S, Lapatto R, Au M, Hughes V, Bianco SD, Min L,
Plummer L, Cerrato F, De Guillebon A, Wu IH, Wahab F, Dwyer A, Kirsch S, Quinton R,
Search WWH ::
Custom Search